BIB logo

BIB ETF

Profile

Name:

ProShares Ultra Nasdaq Biotechnology

Assets under management:

$72 M

Expense ratio:

0.95%

Inception date:

09 April 2010

Last ex-dividend date:

25 September 2024

Next ex-dividend date:

N/A

Description:

BIB ETF is an exchange-traded fund that aims to provide leveraged exposure to the performance of the biotechnology sector. It seeks to amplify returns by investing in biotech stocks, making it suitable for investors looking for higher risk and potential rewards in this industry.
Name
Weight
NASDAQ Bio Index SWAP BNP Paribas
18.27 %
NASDAQ Biotechnology Index SWAP UBS AG
14.16 %
NASDAQ Biotechnology Index SWAP Bank of America NA
13.10 %
Net Other Assets (Liabilities)
6.09 %
TREASURY BILL
5.86 %
NASDAQ Biotechnology Index SWAP Goldman Sachs International
3.51 %
3.16 %
NASDAQ Biotechnology Index SWAP Societe Generale
2.77 %
AMGN logo
Amgen(AMGN)
2.44 %

Holding types

Countries

Sectors

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series
Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
BIB
InvestorPlace25 March 2024

Some of the market's favorite biotech stocks have created immense wealth, as in the recent weight-loss drug stock boom.  On May 26, Viking Therapeutics (NASDAQ: VKTX ) was trading around $20.25.

FAQ

  • What is BIB ETF?
  • Does BIB pay dividends?
  • What stocks are in BIB ETF?
  • What is the current assets under management for BIB?
  • What is BIB average volume?
  • What is BIB expense ratio?
  • What is BIB inception date?

What is BIB ETF?

BIB ETF is an exchange-traded fund that aims to provide leveraged exposure to the performance of the biotechnology sector. It seeks to amplify returns by investing in biotech stocks, making it suitable for investors looking for higher risk and potential rewards in this industry.

Does BIB pay dividends?

Yes, the ProShares Ultra Nasdaq Biotechnology does pays dividends, with the most recent payment being $0.15 per share. The last ex-dividend date was on 25 September 2024, and the next ex-dividend date has not been announced yet

What stocks are in BIB ETF?

As of today, ProShares Ultra Nasdaq Biotechnology inlcudes 222 holdings, with 212 of them being companies from 14 different countries and 1 sectors. The most weighted holdings are NASDAQ Bio Index SWAP BNP Paribas (18.27%), NASDAQ Biotechnology Index SWAP UBS AG (14.16%) and NASDAQ Biotechnology Index SWAP Bank of America NA (13.1%)

What is the current assets under management for BIB?

Assets under management of ProShares Ultra Nasdaq Biotechnology is $72 M

What is BIB average volume?

Average volume of ProShares Ultra Nasdaq Biotechnology is $12 K

What is BIB expense ratio?

Expense ratio of ProShares Ultra Nasdaq Biotechnology is 0.95%

What is BIB inception date?

Inception date of ProShares Ultra Nasdaq Biotechnology is 09 April 2010